Ensysce Biosciences financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

엔시스 바이오사이언시스NASDAQ:ENSC · Nasdaq · Healthcare

$0.4190+6.08%

2026-10-05 close

Ensysce Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $5M. 2024 operating profit was −$7M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy